Vivitra 440mg Injection

About Vivitra 440mg Injection

Vivitra 440 mg Injection contains trastuzumab, a targeted monoclonal antibody used to treat HER2-positive breast and gastric cancers. It works by binding to the HER2 receptor on cancer cells, blocking growth signals and slowing the growth and spread of cancer cells.

Vivitra is administered as an intravenous (IV) infusion by a healthcare professional, either weekly or once every three weeks depending on the treatment plan. Common side effects include fever, headache, cough, rash, infections, and sleep disturbances, while serious risks may include heart problems, allergic reactions, or lung complications. Heart function and vital signs are closely monitored during treatment, and use during pregnancy should be only under strict medical supervision.